Eliquis and Relistor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eliquis (apixaban) and Relistor (methylnaltrexone bromide). Common drug interactions include arthralgia among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Eliquis and Relistor. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,859 Eliquis users. Check the latest studies of Eliquis.

What is Relistor?

Relistor has active ingredients of methylnaltrexone bromide. eHealthMe is studying from 1,659 Relistor users. Check the latest studies of Relistor.



On Jul, 15, 2026

22 people who take Eliquis and Relistor together, and have interactions are studied.

Eliquis and Relistor drug interactions.

What are the common drug interactions of Eliquis and Relistor, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Abdominal distension
  3. Constipation
  4. Diarrhoea
  5. Drug ineffective
  6. Fatigue (feeling of tiredness)
  7. Myalgia (muscle pain)
  8. Nausea (feeling of having an urge to vomit)
  9. Vomiting
  10. Abnormal dreams

male:

  1. Abdominal distension
  2. Constipation
  3. Abdominal pain upper
  4. Balance disorder
  5. Chronic kidney disease
  6. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  7. Cough
  8. Device dislocation
  9. Drug ineffective
  10. Dyskinesia (abnormality or impairment of voluntary movement)

What are the common drug interactions of Eliquis and Relistor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Constipation
  2. Diarrhoea
  3. Dizziness
  4. Dry mouth
  5. Ear infection
  6. Eye swelling
  7. Flushing (the warm, red condition of human skin)
  8. Nausea (feeling of having an urge to vomit)
  9. Pain
  10. Vomiting

50-59:

  1. Arthralgia (joint pain)
  2. Bone pain
  3. Constipation
  4. Disturbance in attention
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Insomnia (sleeplessness)
  8. Peripheral swelling
  9. Thrombosis (formation of a blood clot inside a blood vessel)

60+:

  1. Diarrhoea
  2. Drug ineffective
  3. Abnormal dreams
  4. Anorectal discomfort
  5. Balance disorder
  6. Bladder discomfort
  7. Chronic kidney disease
  8. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  9. Decreased appetite
  10. Eating disorder

What are the existing conditions these people have? *

  1. Constipation: 10 people, 45.45%
  2. Renal Cell Carcinoma (a kidney cancer): 2 people, 9.09%
  3. Pain: 2 people, 9.09%
  4. Orchitis (inflammation of the testes): 2 people, 9.09%
  5. Multiple Myeloma (cancer of the plasma cells): 2 people, 9.09%
  6. Lung Infection: 2 people, 9.09%
  7. Irritable Bowel Syndrome: 2 people, 9.09%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.09%
  9. Cytomegalovirus Infection: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and Relistor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eliquis and Relistor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eliquis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Relistor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eliquis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relistor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on apixaban and methylnaltrexone bromide (the active ingredients of Eliquis and Relistor, respectively), and Eliquis and Relistor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: